Idox plc

(  Idox    or the   Group    or the   Company  )

Exercise of Share Options &

Total Voting Rights

Idox plc (AIM: IDOX) a leading supplier of specialist information management solutions and services, announces that it has issued 169,569 new Ordinary shares of 1 pence each in the Company (“Ordinary Shares”) pursuant to an exercise of options by two employees under its Long Term Incentive Plan 2019.

Applications have been made for the 169,569 new Ordinary Shares to be admitted to trading on AIM (“Admission”). It is expected that Admission will occur at 8.00 a.m. on or around 28 August 2020.

The total number of Ordinary Shares in issue following Admission will be 444,919,622 . The Company holds 1,491,219 Ordinary Shares in treasury. Therefore the total number of Ordinary Shares with voting rights in the Company will be 443,428,403 .

The above figure of 443,428,403 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA’s Disclosure and Transparency Rules.

-Ends-

Enquiries:

Idox plc

+44 (0) 870 333 7101

Chris Stone, Non-Executive Chairman

David Meaden, Chief Executive

Rob Grubb, Chief Financial Officer

Peel Hunt LLP (NOMAD and Broker)

+44 (0) 20 7418 8900

Edward Knight

Nick Prowting

James Steel

MHP Communications

+ 44 (0) 203 128 8100

Reg Hoare 

 idox@mhpc.com

James Bavister

Amy O’Sullivan

About Idox plc

For more information see  www.idoxplc.com   @Idoxgroup  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

Rule 26

Last updated: December 11th, 2020